natalizumab

Known as: Anti-VLA4, Anti-alpha4 integrin, Natalizumab [Chemical/Ingredient] 
A humanized recombinant IgG4 monoclonal antibody directed against the alpha4 subunit of the integrins alpha4beta1and alpha4beta7 with… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2017
010020019922017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Inflammatory bowel disease (IBD) can be categorized as Crohn’s disease (CD) or ulcerative colitis (UC). Both are chronic… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
BACKGROUND Progressive multifocal leukoencephalopathy (PML) is associated with natalizumab treatment. We quantified the risk of… (More)
  • figure 1
  • table 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Natalizumab is the first alpha4 integrin antagonist in a new class of selective adhesion-molecule inhibitors. We… (More)
  • table 1
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Interferon beta is used to modify the course of relapsing multiple sclerosis. Despite interferon beta therapy, many… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
OBJECTIVE Our objective was to test whether natalizumab, an antibody against very late activating antigen (VLA)-4, interferes… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
We describe the clinical course of a patient with multiple sclerosis in whom progressive multifocal leukoencephalopathy (PML), an… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The prior diagnosis of fatal astrocytoma in a 60-year-old man with Crohn's disease treated with natalizumab, a monoclonal… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Natalizumab, a humanized monoclonal antibody against alpha4 integrin, inhibits leukocyte adhesion and migration into… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A 46-year-old woman with relapsing-remitting multiple sclerosis died from progressive multifocal leukoencephalopathy (PML) after… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND In patients with multiple sclerosis, inflammatory brain lesions appear to arise from autoimmune responses involving… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?